Free Trial
ASX:MDC

Medlab Clinical (MDC) Stock Price, News & Analysis

Medlab Clinical logo

About Medlab Clinical Stock (ASX:MDC)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
36,677 shs
Average Volume
N/A
Market Capitalization
$15.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Medlab Clinical Limited, a biotechnology company, researches, develops, and pre-commercializes pharmaceutical and nutraceutical products in Australia. Its drug candidate includes NanaBis, a buccal spray from cannabis oil extract for oncology and pain management; and NanoCBD, a buccal spray from hemp oil extract for mental health. The company also develops NanoCelle, a patented sub-micron drug delivery platform that allows passive diffusion of active pharmaceutical ingredients directly into the bloodstream through oral-buccal, sublingual, intranasal, and transdermal or topical delivery. In addition, it offers virtual clinic services. The company was founded in 2012 and is headquartered in Botany, Australia.

Receive MDC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medlab Clinical and its competitors with MarketBeat's FREE daily newsletter.

MDC Stock News Headlines

Medlab Clinical to be Delisted from ASX
Watch This Robotics Demo Before July 23rd
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."
Medlab Clinical Faces Steep Revenue Decline and Loss
Child Care on College Campuses: What to Know
Clinical Laboratory Technician Salary
See More Headlines

MDC Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Medlab Clinical investors own include Magellan Financial Group (MFG), iSignthis (ISX), FBR (FBR), Embark Early Education (EVO), Dacian Gold (DCN), Constellation Technologies (CT1) and Bod Australia (BDA).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
Construction
Current Symbol
ASX:MDC
CIK
N/A
Fax
N/A
Employees
1,640
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-3,940,000.00
Net Margins
-1,351.41%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$-1,470,000.00
Price / Cash Flow
5.12
Book Value
A($0.31) per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$15.07 million
Optionable
Not Optionable
Beta
0.89
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (ASX:MDC) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners